Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Itamaro Heiden (São Paulo, Brazil), J. Barbosa Sobral (São Paulo, Brazil), J. Alves Jr (São Paulo, Brazil), J. Salge (São Paulo, Brazil), A. Albuquerque (São Paulo, Brazil), C. Fernandes (São Paulo, Brazil), R. Kairalla (São Paulo, Brazil), C. Ribeiro Carvalho (São Paulo, Brazil), R. Souza (São Paulo, Brazil), B. Guedes Baldi (São Paulo, Brazil). Pulmonary Hypertension in Pulmonary Langerhans Cell Histiocytosis: prevalence and the role of Cardiopulmonary Exercise Testing and echocardiogram in predicting it. 3684

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary Hypertension in Pulmonary tuberculosis- A Prognostic Indicator Source: International Congress 2017 – Imaging and lung disease PH Year: 2017 Exercise-induced pulmonary hypertension in patients with systemic sclerosis: Pilot-study Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Exercise-induced pulmonary pressure changes in scleroderma patients – A follow-up study Source: International Congress 2014 – Pulmonary hypertension: right ventricular function, exercise and gas exchange Year: 2014 Usefulness of NT-proBNP dosage during the follow-up of PAH: Comparison with 6MWD Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Relevance of echocardiographic composite index to improve the detection of pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Optimization of PH diagnostic process with IVUS during right heart catheterization Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension Year: 2014 Non-invasive cardiac output assessment in pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Pulmonary Hypertension Source: Research Seminar 2013 - Optimising models for human lung diseases and drug development Year: 2013 Pulmonary Hypertension Source: Eur Respir Rev 2009; 18: 193-194 Year: 2009 Improving the safety of right heart catheterisation in sickle cell disease Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Clinical Features of Pulmonary Hypertension Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease Year: 2012 Cardiac MRI derived right ventriculo-arterial coupling in pulmonary hypertension as a predictor of survival Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Clinical efficacy of Macitentan in patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 Effects on Right Ventricular size and function by Riociguat in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension (The RIVER Study) Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 Prognosis factors of recurrent pulmonary thromboembolism Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 Detection of hepatopulmonary syndrome in patients with liver cirrhosis using 3D contrast echocardiography Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Prognostic value of TDI assessment of right ventricular function in patients with acute pulmonary embolism Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014